Effects of SS320A, a new cysteine derivative, on the change in the number of goblet cells induced by bacterial endotoxin in rat tracheal epithelium

Environmental Toxicology and Pharmacology

Volumn 5, Issue 3, 1998, Pages 173-178

  Takahashi, Koichi ^a   Mizuno, Hiroyuki ^a   Ohno, Hiromitsu ^a   Takeuchi, Masaya ^b   Nagaoka, Shigeru ^c   Kai, Hirofumi ^d   Miyata, Takeshi ^d  

^a Central Research Laboratories   (Japan)

^b Sapporo General Pathology Laboratory   (Japan)

^c Japan Research Institute of Sputum   (Japan)

^d Fac Pharmaceutical Sci   (Japan)

Author keywords

Cysteine derivative; Goblet; Lipopolysaccharide; SS320A

Indexed keywords

ALCIAN BLUE; AMBROXOL; BROMHEXINE; CARBOCISTEINE; CYSTEINE DERIVATIVE; CYSTEINE ETHYL ESTER; DEXAMETHASONE; ENDOTOXIN; FUDOSTEINE; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GOBLET CELL; MALE; MUCUS SECRETION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRACHEA MUCOSA;

EID: 0031806368     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)10072-2     Document Type: Article

References (20)

1. Aikawa T., Shimura S., Sasaki H., Ebina M., Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 101:1992;916-921.
2. Hara S., Hosokawa T. Curative effect of S-carboxymethylcysteine on experimental bronchial disorders due to sulfur dioxide inhalation in rats. Clin. Rep. 13:1979;84-98.
3. Harkema J.R., Hotchkiss J.A. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways - Quantitative histochemistry. Am. J. Pathol. 141:1992;307-317.
4. Iida M., Watanabe K., Tsurufuji M., Takaishi K., Iizuka Y., Tsurufuji S. Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats. Infect. Immun. 60:1992;1268-1272.
5. Lundgren J.D., Kaliner M., Logun C., Shelhamer J.H. Dexamethasone reduces rat tracheal goblet cell hyperplasia produced by human neutrophil products. Exp. Lung Res. 14:1988;853-863.
6. Lundgren J.D., Shelhamer J.H. Pathogenesis of airway mucus hypersecretion. J. Allergy Clin. Immunol. 85:1990;399-417.
7. Nowak D., Antczak A., Krol M., Bialasiewicz P., Pietras T. Antioxidant properties of ambroxol. Free Radic. Biol. Med. 16:1994;517-522.
8. Nowak D., Antczak A., Pietras T., Bialasiewicz P., Krol M. Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice. Eur. Respir. J. 7:1994;1629-1634.
9. Ohtsuka T., Kubota A., Hirano T., Watanabe K., Yoshida H., Tsurufuji M., Iizuka Y., Konishi K., Tsurufuji S. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation. J. Biol. Chem. 271:1996;1651-1659.
10. Rogers D.F., Turner N.C., Marriott C., Jeffery P.K. Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of mucus in rat larynx and trachea in situ. Eur. Respir. J. 2:1989;955-960.
11. Rogers D.F. Airway goblet cells: Responsive and adaptable front-line defenders. Eur. Respir. J. 7:1994;1690-1706.
12. Rudolphus A., Stolk J., Dijkman J.H., Kramps J.A. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am. Rev. Respir. Dis. 147:1993;442-447.
13. Scanlon P.D., Seltzer J., Ingram R.H., Reid L., Drazen J.M. Chronic exposure to sulfur dioxide. Physiologic and histologic evaluation of dogs exposed to 50 or 15 ppm. Am. Rev. Respir. Dis. 135:1987;831-839.
14. Shimizu T., Takahashi Y., Kawaguchi S., Sakakura Y. Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am. J. Respir. Crit. Care Med. 153:1996;1412-1418.
15. Steiger D.J., Hotchkiss J., Bajaj L., Harkema J., Basbaum C. Concurrent increases in the storage and release of mucin-like molecules by rat airway epithelial cells in response to bacterial endotoxin. Am. J. Respir. Cell Mol. Biol. 12:1995;307-314.
16. Stolk J., Rudolphus A., Davies P., Osinga D., Dijkman J.H., Agarwal L., Keeman K.P., Fletcher D., Kramps J.A. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J. Pathol. 167:1992;349-356.
17. Sturgress J., Reid L. The effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary glands, heart, thymus, liver and spleen. Br. J. Exp. Pathol. 54:1973;388-403.
18. Takahashi K., Mizuno H., Ohno H., Kuraishi H., Numata H., Isohama Y., Takahama K., Miyata T. Pharmacological profile on the new mucoactive agent SS320A, a cysteine derivative. Am. J. Respir. Crit. Care Med. 151:1995;A383.
19. Takahashi K., Yokoyama T., Ohno H., Yamaguchi S., Kai H., Nagaoka S., Miyata T. Inhibitory effect of fudostein, a new mucoactive agent, on hyperplasia of goblet cells in rat tracheal epithelium. Eur. Respir. J. Suppl. 10. 25:1997;53s.
20. Yasui S., Nagai A., Aoshiba K., Ozawa Y., Kakuta Y., Konno K. A specific neutrophil elastase inhibitor (ONO-5046.Na) attenuates LPS-induced acute lung inflammation in the hamster. Eur. Respir. J. 8:1995;1293-1299.